We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
N4 Pharma Plc | LSE:N4P | London | Ordinary Share | GB00BYW8QM32 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.825 | 0.80 | 0.85 | 0.825 | 0.825 | 0.83 | 352 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Drug & Proprietary Stores | 0 | -1.03M | -0.0057 | -1.44 | 1.48M |
Date | Subject | Author | Discuss |
---|---|---|---|
19/7/2017 15:54 | Biggest Bill, I am all for a bit of speculation on that front if only to burn the shorters! | bones | |
19/7/2017 15:51 | Unfortunately, at this level the company is now vulnerable to an opportunistic takeover bid. | biggest bill | |
19/7/2017 15:34 | Yes flashheart, good move. | bones | |
19/7/2017 15:31 | Added at this level Bones. Too good a price not to. | flashheart | |
19/7/2017 15:30 | Escapetohome I am also not capitulating, and I do have a lot.Jeez the capitulation is happening once they start posting that they are selling out and bad mouthing it. Even good old backtoskool has only been doing it since 8p, playing it well safe. Where was he when it was heading higher?As it is, now people are being flushed out and telling us on ADVFN, that sounds like the MM's have done their work.....Backtoskool | bones | |
19/7/2017 14:57 | Im not so sure i would sell at this price. Im remaining firm, but i dont have many shares. | escapetohome | |
19/7/2017 14:46 | I'm out! Anything with Beauforts name attached to has aways ended up in disaster for me personally | jpuff | |
19/7/2017 14:11 | Yep it is wish I had of shorted it, as I said 6p was nailed on ages ago. | donald tramp | |
19/7/2017 13:55 | A disappointing share price performance | escapetohome | |
19/7/2017 13:19 | back to front, front to back.whichever way you say it, I'm right and you're wrong.Below IPO is looming, lemmins. | backtogo | |
18/7/2017 14:28 | Sicilian, I believe the 15m warrants were at the old 2p price and became 3.75m at 8p on reorganisation and they have expired or been converted by 7th June this year. So no dilution there. The recent conversion of those warrants has weighed on the recent price.The director options are possibly also at the old rates. Would need to check (as you can do on the prospectus). The shares in issue at the placing date were circa 50m with 21m added via the placing and 21m new warrants in place at 8.5p. In summary I would say the diluted shareholding currently is in the 100m region.I haven't had time to delve deeper but I'm sure you can in time :) | bones | |
17/7/2017 23:46 | ZEBBO are you sure? I've just checked the admission document: Shows 71.7m shares in issue following admission 21.4m warrants to be granted in connection with the placing 1.2m broker warrants 10.8m options to Burnell 3.54m options to Cairns 1.4m options to Titley 0.6m options to Templeton 15m 2016 warrants I've only skimmed and may be wrong but I'm heading towards 125m shares fully diluted? Big difference. Just want to ensure I get the accurate figures. | sicilian_kan | |
17/7/2017 23:31 | Where's the revenue?When will they have any?Whopping placing before end of year. | backtogo | |
17/7/2017 23:24 | Sicilian 75m shares fully diluted | zebbo | |
17/7/2017 23:21 | I have not filtered many but backtogo is for the no hopers pot | zebbo | |
17/7/2017 22:40 | Can someone here enlighten me as to the following: 1. Total number of shares in issue 2. Total number of options outstanding (whether exercisable now or not) and the average exercise price 3. Total number of warrants outstanding (whether exercisable now or not) and the average exercise price Thanks in advance. Only provable answers sought - no speculation. | sicilian_kan | |
17/7/2017 22:37 | backtofront, have you actually turned 5 yet? | bones | |
14/7/2017 21:09 | Similar criticism of OPTI in the early months.Didn't stop it from appreciating by 1000%+. | patientcapital | |
14/7/2017 20:52 | This is a young Pharma company developing new products, so of course there's no income stream yet. In fact the end game could be a take-over rather than a regular income stream. Some posters here need to do a bit of research before throwing rocks around!If you want a company with a well established revenue stream, try the ftse100. | bdog51 | |
14/7/2017 19:50 | backtogo speaks sense, but some are blind and can only see the other side of the fence. No income and just cash burn. | donald tramp | |
14/7/2017 11:57 | It seems to be Cantor Fitzgerald permanently the MM on the offer and aggressively so. Guess they are the ones with the supply to unload in recent weeks. | bones | |
14/7/2017 11:56 | Mine went through on NEX. Wondered why it hadn't showed up. | bones | |
14/7/2017 11:53 | And another 20K for me at 7.22p to bring my average down a little! | parob | |
14/7/2017 11:49 | Nice Bones, don't listen to the haters, trust your research, back your conviction. Easy to sit in the sidelines and throw stones when you risk nothing. The cream always rises to the top, cracking Mgmt team at N4 and a fantastic business model. The market is there to be exploited, in time they will do just that | trotterstrading |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions